Total Payments
$16,495
2024 Payments
$216.22
Companies
9
Transactions
24
Medicare Patients
1,577
Medicare Billing
$112,988
Payment Breakdown by Category
Consulting$10,560 (64.0%)
Travel$3,836 (23.3%)
Food & Beverage$1,321 (8.0%)
Education$778.97 (4.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,560 | 5 | 64.0% |
| Travel and Lodging | $3,836 | 6 | 23.3% |
| Food and Beverage | $1,321 | 12 | 8.0% |
| Education | $778.97 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $12,284 | 11 | $0 (2019) |
| Augmenix, Inc. | $2,742 | 4 | $0 (2018) |
| Boston Scientific Corporation | $647.50 | 2 | $0 (2024) |
| Teleflex LLC | $304.80 | 2 | $0 (2023) |
| PROCEPT BioRobotics Corporation | $168.72 | 1 | $0 (2024) |
| Palette Life Sciences, Inc. | $156.94 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $100.62 | 1 | $0 (2019) |
| KARL STORZ Endoscopy-America | $55.24 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $35.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.22 | 2 | PROCEPT BioRobotics Corporation ($168.72) |
| 2023 | $904.80 | 3 | Boston Scientific Corporation ($600.00) |
| 2022 | $156.94 | 1 | Palette Life Sciences, Inc. ($156.94) |
| 2019 | $12,420 | 13 | F. Hoffmann-La Roche AG ($12,284) |
| 2018 | $194.23 | 2 | Augmenix, Inc. ($138.99) |
| 2017 | $2,603 | 3 | AUGMENIX, INC. ($2,603) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $168.72 | General |
| Category: UROLOGY | ||||||
| 03/14/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: rezum_URO | ||||||
| 10/04/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $152.40 | General |
| Category: Interventional Urology | ||||||
| 08/04/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/14/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $152.40 | General |
| Category: Interventional Urology | ||||||
| 11/15/2022 | Palette Life Sciences, Inc. | — | Food and Beverage | In-kind items and services | $156.94 | General |
| 06/26/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| Category: None | ||||||
| 06/26/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $568.81 | General |
| Category: None | ||||||
| 06/26/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $263.04 | General |
| Category: None | ||||||
| 06/26/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $198.16 | General |
| Category: None | ||||||
| 06/26/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $61.86 | General |
| Category: None | ||||||
| 05/05/2019 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $35.83 | General |
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $3,610.00 | General |
| Category: None | ||||||
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $2,058.80 | General |
| Category: None | ||||||
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $781.33 | General |
| Category: None | ||||||
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Education | In-kind items and services | $778.97 | General |
| Category: None | ||||||
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $101.70 | General |
| Category: None | ||||||
| 04/14/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: None | ||||||
| 02/26/2019 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $100.62 | General |
| 10/09/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $138.99 | General |
| Category: Oncology | ||||||
| 09/26/2018 | KARL STORZ Endoscopy-America | NEO Stream Connect (Device) | Food and Beverage | In-kind items and services | $55.24 | General |
| Category: OR1 | ||||||
| 04/10/2017 | AUGMENIX, INC. | SpaceOAR (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 03/29/2017 | AUGMENIX, INC. | SpaceOAR (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Oncology | ||||||
| 02/01/2017 | AUGMENIX, INC. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $102.74 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 441 | 528 | $117,081 | $30,635 |
| 2022 | 11 | 396 | 481 | $104,705 | $29,762 |
| 2021 | 11 | 422 | 524 | $98,461 | $30,780 |
| 2020 | 10 | 318 | 399 | $73,045 | $21,811 |
Total Patients
1,577
Total Services
1,932
Medicare Billing
$112,988
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 146 | 181 | $41,599 | $9,261 | 22.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 77 | 113 | $24,747 | $6,810 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 46 | 56 | $15,064 | $4,547 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $5,166 | $1,580 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 28 | 28 | $6,384 | $1,579 | 24.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,124 | $1,541 | 30.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 17 | 17 | $5,984 | $1,519 | 25.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 26 | $4,732 | $1,377 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 16 | $3,193 | $1,072 | 33.6% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 20 | 21 | $1,764 | $460.44 | 26.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 18 | 18 | $1,764 | $446.25 | 25.3% |
| 76857 | Limited ultrasound scan of pelvis | Facility | 2023 | 23 | 24 | $1,560 | $441.76 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 143 | 193 | $35,517 | $9,857 | 27.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 53 | 76 | $16,644 | $4,384 | 26.3% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 14 | 15 | $11,704 | $3,651 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 42 | $11,354 | $3,433 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 42 | 42 | $9,576 | $2,547 | 26.6% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 16 | 16 | $5,647 | $1,770 | 31.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 27 | 29 | $5,302 | $1,546 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $4,440 | $1,318 | 29.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 17 | 18 | $1,518 | $473.79 | 31.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2022 | 16 | 16 | $1,568 | $407.05 | 26.0% |
| 76857 | Limited ultrasound scan of pelvis | Facility | 2022 | 22 | 22 | $1,435 | $374.59 | 26.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 150 | 204 | $33,692 | $10,966 | 32.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 65 | 86 | $19,163 | $5,333 | 27.8% |
About Dr. Mark Katz, MD
Dr. Mark Katz, MD is a Urology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437390507.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Katz, MD has received a total of $16,495 in payments from pharmaceutical and medical device companies, with $216.22 received in 2024. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($10,560).
As a Medicare-enrolled provider, Katz has provided services to 1,577 Medicare beneficiaries, totaling 1,932 services with total Medicare billing of $112,988. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Boston, MA
- Active Since 03/18/2009
- Last Updated 01/03/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1437390507
Products in Payments
- Non-Covered Product (Drug) $12,284
- SpaceOAR (Device) $2,742
- SpaceOAR VUE System - 10mL (Device) $600.00
- UROLIFT (Device) $304.80
- AQUABEAM SYSTEM (Device) $168.72
- NEO Stream Connect (Device) $55.24
- Rezum Generator (Device) $47.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Boston
Dr. Christopher Cutie, Md, MD
Urology — Payments: $3.8M
Urology $3.8M
Brian Eisner, Md, MD
Urology — Payments: $594,130
Urology $594,130
Tony Luongo, Md, MD
Urology — Payments: $531,062
Urology $531,062
Dr. Shahin Tabatabaei, Md, MD
Urology — Payments: $165,699
Urology $165,699
Ricardo Munarriz, M.d, M.D
Urology — Payments: $138,151
Urology $138,151
Richard Babayan, M.d, M.D
Urology — Payments: $115,932
Urology $115,932